[1] 王维维,沈茜.Th17细胞和Treg细胞的细胞因子调节网络[J].生命的化学,2010,30(2):269-273.[2] Zhao P, Wang C, Liu W, et al. Causes and outcomes of acute liver failure in China[J]. PLoS One, 2013,8(11):e80991.[3] Sakaguchi S, Sakaguchi N, Asano M, et al. Immunological self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains(CD25) Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases[J]. J Immunol, 2011,186(7):3808-3821.[4] 张蓝芳.Th17细胞和Treg细胞与某些疾病关系的研究进展[J].济宁医学院学报,2011,34(1):189-192.[5] Wing K, Fehérvári Z, Sakaguchi S, et al. Emerging possibilities in the development and function of regulatory T cells[J]. Immunology, 2006,18(7):991-1000.[6] 中华医学会感染病学分会肝衰竭与人工肝学组和中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊疗指南[J].实用肝脏病杂志,2013,16(3):210-216.[7] 刘新,娄金丽,白丽,等.流式细胞术分析小鼠肝纤维化时机体免疫细胞的变化[J].首都医科大学学报,2013,34(4):540-544.[8] Yang J, Yi P, Wei L, et al. Phenotypes and clinical significance of circulating CD4+CD25+ regulatory T cell(Tregs) in patients with acute-on-chronic liver failure(ACLF)[J]. J Transl Med, 2012,10:193.[9] 褚小刚,陈辉,王鲁文,等.急性肝衰竭患者外周血调节性T细胞比率及活性变化[J].中华实验外科杂志,2013,30(1):147-149.[10] 魏秀丽,黄志.双类似物对重症肌无力幼鼠Foxp3+CD4+CD25+Tregs的作用机制[J].中华实用儿科临床杂志,2013,14(28):1108-1111.[11] Niu Y H, Yin D L, Liu H L, et al. Restoring the Treg cell to Th17 cell ratio may alleviate related acute-on-chronic liver failure[J]. World J Gastroenterol, 2013,19(26):4146-4154.[12] Chen X, Du Y, Huang Z, et al. CD4+CD25+ Treg derived from hepatocellular carcinoma mice inhibits tumor immunity[J]. Immunology Letters, 2012,148:83-89.[13] Almeida J, Polvorosa M A, Gonzalez-Quintela A, et al. Decreased peripheral blood CD4+/CD25+regulatory T cells in patients with alcoholic hepatitis[J]. Alcohol Clin Exp Res, 2013,8(37):1361-1368.[14] 苏立稳,刘宇,杨萱.中西药联合治疗失代偿期乙型肝炎肝硬化30例[J].解放军医药杂志,2013,25(5):63-65.[15] 胡孝彬.肝功能损害诊断思维[J].中国煤炭工业医学杂志,2012,15(3):470-473. |